We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SACHRP: FDA Should Revise Informed Consent Waivers to Match HHS Rules
SACHRP: FDA Should Revise Informed Consent Waivers to Match HHS Rules
The Secretary’s Advisory Committee on Human Research Protections is recommending that the FDA revise its informed consent waivers for cluster randomized trials to mirror HHS rules.